MINI REVIEW
Published on 30 May 2025
GLP-1R in diabetes mellitus: from basic discovery to therapeutics development
doi 10.3389/fphar.2025.1610512
- 309 views
- Frontiers in Pharmacology
- Translational Pharmacology
- Research Topics
- Optimizing GLP-1 Receptor Agonist Use: Mechanisms, Clinical Applications, and Safety Profiles
Optimizing GLP-1 Receptor Agonist Use: Mechanisms, Clinical Applications, and Safety Profiles
5,237
Total downloads
25k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 22 May 2025
Glucagon-like peptide-1, fibroblast growth factor 21, and other endocrine responses to alcohol ingestion in women before and after metabolic surgery
doi 10.3389/fphar.2025.1575156
- 492 views
ORIGINAL RESEARCH
Published on 04 Sep 2024
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may reduce the risk of developing cancer-related lymphedema following axillary lymph node dissection (ALND)
doi 10.3389/fphar.2024.1457363
- 4,942 views
CLINICAL TRIAL
Published on 22 Aug 2024
Pharmacokinetics and safety profiles of beinaglutide injection, a recombinant human GLP-1, in adults with overweight/obesity: results from a phase I clinical trial
doi 10.3389/fphar.2024.1433587
- 1,591 views
- 1 citation
ORIGINAL RESEARCH
Published on 16 Aug 2024
The GLP-1 receptor agonist exendin-4 reduces taurine and glycine in nucleus accumbens of male rats, an effect tentatively involving the nucleus tractus solitarius
doi 10.3389/fphar.2024.1439203
- 1,815 views
- 2 citations
ORIGINAL RESEARCH
Published on 08 Jul 2024
Pharmacovigilance study of GLP-1 receptor agonists for metabolic and nutritional adverse events
doi 10.3389/fphar.2024.1416985
- 5,007 views
- 7 citations
CASE REPORT
Published on 18 Apr 2024
GLP-1 receptor agonist as an effective treatment for breast cancer-related lymphedema: a case report
doi 10.3389/fonc.2024.1392375
- 9,708 views
- 3 citations
